510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

Stat Profile Prime ABG Analyzer System

K151982510(k) TraditionalCleared Sep 10, 201555-day reviewClass II21 CFR 862.1120Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nova Biomedical Corporation · CHL Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph

Cleared on Sep 10, 2015 as substantially equivalent to K142220 (Nova Biomedical Corporation, 2014) after a 55-day review. Its family tree reaches back 4 generations to 2006. It has been recalled once.

Decided
Sep 10, 2015
Review
55 days
Class
Class II
Product code
CHL
Recalls
1
Predicates
1

Its longest line of descent runs back 4 generations to K061830 (2006). No later device cites it as a predicate yet.

  1. Root · 4 generations backK061830 Stat Profile Critical Care Xpress (CCX), Model 1+Nova Biomedical Corp. · 2006
  2. 3 generations backK110648 Nova Stat Profile Phox Ultra Analyzer SystemNova Biomedical Corporation · 2011
  3. 2 generations backK131703 Nova Stat Profile Prime CCS Analyzer SystemNova Biomedical Corporation · 2014 · Recalled
  4. 1 generation backK142220 Stat Profile Prime ABG Analyzer System (incl. Controls, Calibrators)Nova Biomedical Corporation · 2014 · Recalled
  5. This deviceK151982 Stat Profile Prime ABG Analyzer SystemNova Biomedical Corporation · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K061830Stat Profile Critical Care Xpress (CCX), Model 1+Nova Biomedical Corp.2006—
−3K110648Nova Stat Profile Phox Ultra Analyzer SystemNova Biomedical Corporation2011—
−2K131703Nova Stat Profile Prime CCS Analyzer SystemNova Biomedical Corporation20141
−1K142220Stat Profile Prime ABG Analyzer System (incl. Controls, Calibrators)Nova Biomedical Corporation20141
0 (this device)K151982Stat Profile Prime ABG Analyzer SystemNova Biomedical Corporation2015—
FIG. 1 — Lineage of K151982, 2006–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CHL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CHL device

  1. #1 K252207 ABL90 FLEX PLUS System, safeCLINITUBESscore 14.1 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142220Stat Profile Prime ABG Analyzer System (incl. Controls, Calibrators)
Summary page 4
…: Blood gases (PC0O2, PO2) and blood pH Test System Classification Name: Multiple Blood Gases and Blood pH system 75CHL 862.1120 I Product Codes: CHL Predicate Device: K142220 - Stat Profile® Prime ABG Analyzer System Device Description: The Stat Profile® Prime ABG Analyzer is a small, low cost blood ga…
Nova Biomedical Corporation20141

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 19, 2017Class IIZ-2732-2017Software designSoftware- scheduled A-QC analysis could initiate prior to a patient result being released by the operator and result in the pending patient result being overwritten with the A-QC test results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 2.6 years on median.
  • 2 of the 4 ancestors have a recall of any class.

How does its category compare?

All CHL devices

CHL Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · CHL

1in 2025

2007: 12008: 12010: 12011: 42012: 42013: 52014: 32015: 42016: 32017: 12018: 12020: 42021: 22023: 52024: 12025: 12026 (partial year): 1
2007high 5 (2013) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CHL

267in 2023

2011: 108 days median2012: 65 days median2013: 152 days median2014: 68 days median2015: 155 days median2016: 306 days median2020: 100 days median2023: 267 days median
2007high 306 (2016) · low 65 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CHL

13so far in 2026, the most since 2007

2007: 62008: 52009: 62010: 72011: 12012: 92013: 12014: 12015: 32016: 12017: 12018: 32020: 22023: 42024: 92026 (partial year): 13
2007high 13 (2026) · low 0 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CHL

210in 2025

2007: 162008: 402009: 742010: 202011: 502012: 642013: 622014: 932015: 552016: 1182017: 2062018: 1742019: 1412020: 1172021: 1472022: 1382023: 1772024: 1962025: 210
2007high 210 (2025) · low 16 (2007)2025

MAUDE reports naming product code CHL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—616
20081—540
20090—674
20101—720
20114108150
2012465964
20135152162
2014368193
20154155355
201633061118
20171—1206
20181—3174
20190—0141
202041002117
20212—0147
20220—0138
202352674177
20241—9196
20251—0210
20261—13—

What is it indicated for?

The Stat Profile Prime ABG Analyzer System is intended for in vitro diagnostic use by health care professionals in clinical laboratory settings and for point-of-care usage for the quantitative determination of pH, PCO2, and PO2 in heparinized whole blood.

PCO2, PO2, pH: Whole blood measurement of blood gases is used in the diagnosis and treatment of life threatening acid-base disturbances.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K151982: Stat Profile Prime ABG Analyzer System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K151982

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026